Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBD-OH
2024-518455-28-00Phase 2Authorised
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cannabidiol in alcohol use disorder (AUD) (3 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoints: Continuous alcohol abstinence at month 1 after discharge (week 6) and Biologically confirmed continuous abstinence via EtG. Planned start Oct 2024; status: authorised.
02
Drugs
cannabidiol
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on 2024-518455-28-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518455-28-00.